Literature DB >> 20035050

Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm.

Ciara M Chamberlain1, Lisa S Ang, Wendy A Boivin, Dawn M Cooper, Sarah J Williams, Hongyan Zhao, Alon Hendel, Maggie Folkesson, Jesper Swedenborg, Michael F Allard, Bruce M McManus, David J Granville.   

Abstract

Granzyme B (GZMB) is a serine protease that is abundantly expressed in advanced human atherosclerotic lesions and may contribute to plaque instability. Perforin is a pore-forming protein that facilitates GZMB internalization and the induction of apoptosis. Recently a perforin-independent, extracellular role for GZMB has been proposed. In the current study, the role of GZMB in abdominal aortic aneurysm (AAA) was assessed. Apolipoprotein E (APOE)(-/-) x GZMB(-/-) and APOE(-/-) x perforin(-/-) double knockout (GDKO, PDKO) mice were generated to test whether GZMB exerted a causative role in aneurysm formation. To induce aneurysm, mice were given angiotensin II (1000 ng/kg/min) for 28 days. GZMB was found to be abundant in both murine and human AAA specimens. GZMB deficiency was associated with a decrease in AAA and increased survival compared with APOE-KO and PDKO mice. Although AAA rupture was observed frequently in APOE-KO (46.7%; n = 15) and PDKO (43.3%; n = 16) mice, rupture was rarely observed in GDKO (7.1%; n = 14) mice. APOE-KO mice exhibited reduced fibrillin-1 staining compared with GDKO mice, whereas in vitro protease assays demonstrated that fibrillin-1 is a substrate of GZMB. As perforin deficiency did not affect the outcome, our results suggest that GZMB contributes to AAA pathogenesis via a perforin-independent mechanism involving extracellular matrix degradation and subsequent loss of vessel wall integrity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035050      PMCID: PMC2808106          DOI: 10.2353/ajpath.2010.090700

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute.

Authors:  M Wassef; B T Baxter; R L Chisholm; R L Dalman; M F Fillinger; J Heinecke; J D Humphrey; H Kuivaniemi; W C Parks; W H Pearce; C D Platsoucas; G K Sukhova; R W Thompson; M D Tilson; C K Zarins
Journal:  J Vasc Surg       Date:  2001-10       Impact factor: 4.268

2.  Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome.

Authors:  T E Bunton; N J Biery; L Myers; B Gayraud; F Ramirez; H C Dietz
Journal:  Circ Res       Date:  2001-01-19       Impact factor: 17.367

3.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

Authors:  A Daugherty; M W Manning; L A Cassis
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

4.  Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor.

Authors:  Kirk A Hance; Monika Tataria; Scott J Ziporin; Jason K Lee; Robert W Thompson
Journal:  J Vasc Surg       Date:  2002-02       Impact factor: 4.268

5.  Relaxin regulates fibrillin 2, but not fibrillin 1, mRNA and protein expression by human dermal fibroblasts and murine fetal skin.

Authors:  Chrishan S Samuel; Lynn Y Sakai; Edward P Amento
Journal:  Arch Biochem Biophys       Date:  2003-03-01       Impact factor: 4.013

6.  Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall.

Authors:  Monsur Kazi; Johan Thyberg; Piotr Religa; Joy Roy; Per Eriksson; Ulf Hedin; Jesper Swedenborg
Journal:  J Vasc Surg       Date:  2003-12       Impact factor: 4.268

7.  Expression of granzyme B in human articular chondrocytes.

Authors:  Kiwamu Horiuchi; Seiji Saito; Ryohei Sasaki; Taisuke Tomatsu; Yoshiaki Toyama
Journal:  J Rheumatol       Date:  2003-08       Impact factor: 4.666

8.  Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.

Authors:  Kiran Saraff; Fjoralba Babamusta; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-10       Impact factor: 8.311

9.  Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity.

Authors:  Jonathan C Choy; Paul C McDonald; Agripina C Suarez; Vivian H Y Hung; Janet E Wilson; Bruce M McManus; David J Granville
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

Review 10.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

View more
  25 in total

Review 1.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

2.  Cleavage of Notch1 by granzyme B disables its transcriptional activity.

Authors:  Geert van Tetering; Niels Bovenschen; Jan Meeldijk; Paul J van Diest; Marc Vooijs
Journal:  Biochem J       Date:  2011-07-15       Impact factor: 3.857

3.  Granzyme B-expressing neutrophils correlate with bacterial load in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques.

Authors:  Joshua T Mattila; Pauline Maiello; Tao Sun; Laura E Via; JoAnne L Flynn
Journal:  Cell Microbiol       Date:  2015-03-12       Impact factor: 3.715

4.  Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Reena Mourya; Jorge A Bezerra
Journal:  J Hepatol       Date:  2013-10-02       Impact factor: 25.083

5.  Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice.

Authors:  P R Hiebert; D Wu; D J Granville
Journal:  Cell Death Differ       Date:  2013-08-02       Impact factor: 15.828

6.  Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1.

Authors:  Wendy A Boivin; Marlo Shackleford; Amanda Vanden Hoek; Hongyan Zhao; Tillie L Hackett; Darryl A Knight; David J Granville
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

7.  Analysis of positional candidate genes in the AAA1 susceptibility locus for abdominal aortic aneurysms on chromosome 19.

Authors:  John H Lillvis; Yoshiki Kyo; Gerard Tromp; Guy M Lenk; Ming Li; Qing Lu; Robert P Igo; Natzi Sakalihasan; Robert E Ferrell; Charles M Schworer; Zoran Gatalica; Susan Land; Helena Kuivaniemi
Journal:  BMC Med Genet       Date:  2011-01-19       Impact factor: 2.103

8.  Serpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm.

Authors:  L S Ang; W A Boivin; S J Williams; H Zhao; T Abraham; K Carmine-Simmen; B M McManus; R C Bleackley; D J Granville
Journal:  Cell Death Dis       Date:  2011-09-08       Impact factor: 8.469

Review 9.  Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm.

Authors:  Bo Liu; David J Granville; Jonathan Golledge; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

10.  Granzyme B prevents aberrant IL-17 production and intestinal pathogenicity in CD4+ T cells.

Authors:  Michael J Greer; Kathleen G McClanahan; Kristen L Hoek; Ali Nazmi; M Blanca Piazuelo; Kshipra Singh; Keith T Wilson; Danyvid Olivares-Villagómez
Journal:  Mucosal Immunol       Date:  2021-06-28       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.